Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Özlem Topaloglu"'
Publikováno v:
HemaSphere, Vol 7, p e47689ed (2023)
Externí odkaz:
https://doaj.org/article/5b0d5280e6044d0180410e3885f4022e
Publikováno v:
HemaSphere, Vol 7, p e9648305 (2023)
Externí odkaz:
https://doaj.org/article/a6e1c5f71380406d8260bbbb0052ce38
Publikováno v:
HemaSphere, Vol 7, p e3399775 (2023)
Externí odkaz:
https://doaj.org/article/52d8b52f81c64b89a12d0ab02d543b97
Autor:
Wolfgang Engel, Gregor Schlüter, Christian Müller, Detlef Böhm, Arvind Dev, Stephan Wolf, Karim Nayernia, Ibrahim M. Adham, Andreas Meinhardt, Özlem Topaloglu, Khailun Tseden
Publikováno v:
Molecular Reproduction and Development. 74:273-279
During mammalian spermiogenesis somatic histones are replaced at first by transition proteins, which are in turn replaced by the protamines, forming the sperm nucleoprotamines. It is believed that transition protein 2 (Tnp2) is necessary for maintain
Publikováno v:
Biochemical and Biophysical Research Communications. 289:597-601
During the final stages of spermatogenesis, round spermatids undergo several morphological, biochemical, and physiological modifications which result in the formation of mature spermatozoa. One of these is the nuclear condensation, achieved by the re
Publikováno v:
Molecular Reproduction and Development. 58:368-375
During spermiogenesis, the successive replacement of somatic histones by basic proteins, the transition nuclear proteins and protamines, allows normal sperm condensation. Transition nuclear protein 2 (TNP2) is transcribed postmeiotically in round spe
Autor:
Ibrahim M. Adham, Adolf F. Holstein, Wolfgang Engel, Karim Nayernia, Özlem Topaloglu, Elke Burkhardt-Göttges, C. Dixkens
Publikováno v:
Molecular human reproduction. 7(6)
It is believed that the transition proteins (Tnp1 and Tnp2) participate in the removal of the nucleohistones and in the initial condensation of the spermatid nucleus. Later in spermatogenesis, Tnp1 and Tnp2 are replaced by the protamines 1 and 2. In
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 26 (2020)
Defibrotide is approved to treat hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) with renal/pulmonary dysfunction following hematopoietic cell transplantation (HCT) in adult and pediatric patients in the United States, and to
Externí odkaz:
https://doaj.org/article/d3fbf9b72f334a198d4e061a29d12963
Autor:
Khailun Tseden, Özlem Topaloglu, Andreas Meinhardt, Arvind Dev, Ibrahim Adham, Christian Müller, Stephan Wolf, Detlef Böhm, Gregor Schlüter, Wolfgang Engel, Karim Nayernia
Publikováno v:
Molecular Reproduction & Development; Mar2007, Vol. 74 Issue 3, p273-279, 7p